Literature DB >> 4442669

Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range.

K Kosaka, R Hagura, T Kuzuya, N Kuzuya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4442669     DOI： 10.1007/BF01219540

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  13 in total

1.  Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation.

Authors:  W G Ryan; T B Schwartz; A F Nibbe
Journal:  Diabetes       Date:  1971-06       Impact factor: 9.461

2.  Studies on the pathogenesis of diabetes in acromegaly.

Authors:  R Luft; E Cerasi; C A Hamberger
Journal:  Acta Endocrinol (Copenh)       Date:  1967-12

3.  Early insulin responses to glucose and to tolbutamide in maturity-onset diabetes.

Authors:  N Varsano-Aharon; E Echemendia; R S Yalow; S A Berson
Journal:  Metabolism       Date:  1970-06       Impact factor: 8.694

4.  Further studies on healthy subjects with low and high insulin response to glucose infusion.

Authors:  E Cerasi; R Luft
Journal:  Acta Endocrinol (Copenh)       Date:  1967-06

5.  Changes in plasma insulin and glucose tolerance in stable diabetes in a young woman.

Authors:  K Kosaka; R Hagura; R Saito; F Tsukamoto; T Kuzuya
Journal:  Diabetes       Date:  1969-07       Impact factor: 9.461

6.  Is there a delay in the plasma insulin response of patients with chemical diabetes mellitus?

Authors:  G M Reaven; S W Shen; A Silvers; J W Farquhar
Journal:  Diabetes       Date:  1971-06       Impact factor: 9.461

7.  Plasma insulin responses to glucose in femoral, hepatic, and pancreatic veins in dogs.

Authors:  Y Kanazawa; T Kuzuya; T Ide; K Kosaka
Journal:  Am J Physiol       Date:  1966-08

8.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

9.  Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.

Authors:  G Boden; J S Soeldner; R E Gleason; A Marble
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808
View more
  14 in total

1.  Risk factors for worsening to diabetes in subjects with impaired glucose tolerance.

Authors:  T Kadowaki; Y Miyake; R Hagura; Y Akanuma; H Kajinuma; N Kuzuya; F Takaku; K Kosaka
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

2.  Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat.

Authors:  M Otani; M Yamamoto; M Harada; M Otsuki
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

3.  The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects.

Authors:  Sang Youl Rhee; Joo Young Kim; Suk Chon; You Cheol Hwang; In Kyung Jeong; Seungjoon Oh; Kyu Jeung Ahn; Ho Yeon Chung; Jeong-Taek Woo; Sung Woon Kim; Jin-Woo Kim; Young Seol Kim
Journal:  Korean Diabetes J       Date:  2010-06-30

4.  Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

Authors:  K Kosaka; T Kuzuya; Y Akanuma; R Hagura
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

5.  Pathophysiology of gestational diabetes mellitus in lean Japanese pregnant women in relation to insulin secretion or insulin resistance.

Authors:  Shigeru Inoue; Yutaka Kozuma; Michio Miyahara; Toshiyuki Yoshizato; Yuji Tajiri; Daizo Hori; Kimio Ushijima
Journal:  Diabetol Int       Date:  2020-02-08

6.  Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes.

Authors:  Naoko Tajima; Takashi Kadowaki; Taro Okamoto; Asako Sato; Kotoba Okuyama; Toshiomi Minamide; Juan Camilo Arjona Ferreira
Journal:  J Diabetes Investig       Date:  2013-07-21       Impact factor: 4.232

7.  Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes.

Authors:  Atsunori Kashiwagi; Takashi Kadowaki; Naoko Tajima; Kenji Nonaka; Tadaaki Taniguchi; Mikio Nishii; Juan Camilo Arjona Ferreira; John M Amatruda
Journal:  J Diabetes Investig       Date:  2011-10-07       Impact factor: 4.232

8.  Report of the committee on the classification and diagnostic criteria of diabetes mellitus.

Authors:  Yutaka Seino; Kishio Nanjo; Naoko Tajima; Takashi Kadowaki; Atsunori Kashiwagi; Eiichi Araki; Chikako Ito; Nobuya Inagaki; Yasuhiko Iwamoto; Masato Kasuga; Toshiaki Hanafusa; Masakazu Haneda; Kohjiro Ueki
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

9.  Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide.

Authors:  Kyoko Kudo-Fujimaki; Takahisa Hirose; Tomoaki Yoshihara; Fumihiko Sato; Yuki Someya; Chie Ohmura; Akio Kanazawa; Yoshio Fujitani; Hirotaka Watada
Journal:  J Diabetes Investig       Date:  2013-11-05       Impact factor: 4.232

10.  Longitudinal changes in insulin sensitivity, insulin secretion, beta cell function and glucose effectiveness during development of non-diabetic hyperglycemia in a Japanese population.

Authors:  Toru Aizawa; Keishi Yamauchi; Masayuki Yamada
Journal:  Springerplus       Date:  2014-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.